US 8198470
Crystalline form II of tigecycline and processes for preparation thereof
granted A61PA61P31/00
Quick answer
US patent 8198470 (Crystalline form II of tigecycline and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P31/00